{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:03:11Z","timestamp":1781024591662,"version":"3.54.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":76,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.100935","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:54:59Z","timestamp":1774396499000},"page":"100935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Liver Function Tests, Liver Stiffness, and Portal Pressure: Portal-Systemic Shunting as a New Endpoint for Clinical Trials of Cirrhosis and Portal Hypertension"],"prefix":"10.1016","volume":"5","author":[{"given":"Andrew P.","family":"Keaveny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart C.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne C.","family":"Imperial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2126-9442","authenticated-orcid":false,"given":"Michael P.","family":"McRae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Touraj","family":"Shokati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0454-3566","authenticated-orcid":false,"given":"Gregory T.","family":"Everson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.gastha.2026.100935_bib1","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMe2505834","article-title":"Redefining end points in MASH cirrhosis","volume":"392","author":"Garcia-Tsao","year":"2025","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.gastha.2026.100935_bib2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"17","key":"10.1016\/j.gastha.2026.100935_bib3","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMra2403308","article-title":"Noninvasive assessment of liver fibrosis","volume":"393","author":"Castera","year":"2025","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.gastha.2026.100935_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13786","article-title":"Within individual reproducibility of a dual sample oral cholate challenge test (DuO) and other simplified versions of the HepQuant test","volume":"17","author":"McRae","year":"2024","journal-title":"Clin Transl Sci"},{"issue":"6","key":"10.1016\/j.gastha.2026.100935_bib5","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/jalm\/jfae094","article-title":"A validated LC-MS\/MS assay for the quantification of cholate isotopes in human serum","volume":"9","author":"Helmke","year":"2024","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.gastha.2026.100935_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120325","article-title":"Assessment of the performance of a dual-sample oral cholate challenge test: the HepQuant DuO test","volume":"574","author":"McRae","year":"2025","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.gastha.2026.100935_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/bcpt.13980","article-title":"Advances in noninvasive measurement of liver function and physiology: the HepQuant DuO test","volume":"134","author":"McRae","year":"2024","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.gastha.2026.100935_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/apt.18386","article-title":"Cholate shunt, oral cholate challenge and endoscopic lesions of portal hypertension: the SHUNT-V study","volume":"61","author":"Shiffman","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastha.2026.100935_bib9","doi-asserted-by":"crossref","first-page":"e890","DOI":"10.1016\/j.cgh.2021.04.030","article-title":"HepQuant SHUNT detects portal hypertension in early stages of clinically compensated chronic liver disease","volume":"20","author":"Wieland","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.100935_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejim.2024.11.029","article-title":"Measuring the risk of clinical adverse events (RISK ACE) by quantifying liver function: a patient-centric model","volume":"132","author":"Kittelson","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.gastha.2026.100935_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/apt.18054","article-title":"Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices","volume":"60","author":"Hassanein","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.gastha.2026.100935_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/lci2.70027","article-title":"Initial clinical experience with the oral cholate challenge test: results from the 2023\u20132024 Early Access Program","volume":"6","author":"Gordon","year":"2025","journal-title":"Liver Int Commun"},{"issue":"11","key":"10.1016\/j.gastha.2026.100935_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000276","article-title":"Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: a randomized Phase Ib study","volume":"7","author":"Lawitz","year":"2023","journal-title":"Hepatol Commun"},{"issue":"10","key":"10.1016\/j.gastha.2026.100935_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.gastha.2025.100785","article-title":"The cholate challenge test quantified baseline functional heterogeneity and improvement in response to resmetirom in MASH-related Child-Pugh A cirrhosis","volume":"4","author":"Alkhouri","year":"2025","journal-title":"Gastro Hep Adv"},{"issue":"3","key":"10.1016\/j.gastha.2026.100935_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/apt.18128","article-title":"Editorial: reading the cholate\u2014a new gateway to portal hypertension and oesophageal varices: authors' reply","volume":"60","author":"Hassanein","year":"2024","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326000567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326000567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:51:21Z","timestamp":1781023881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326000567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326000567"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.100935","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond Liver Function Tests, Liver Stiffness, and Portal Pressure: Portal-Systemic Shunting as a New Endpoint for Clinical Trials of Cirrhosis and Portal Hypertension","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.100935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"100935"}}